Tigecycline generics are typically more affordable compared to the brand name version. According to Drug Patent Watch, the patent for Tigecycline expired in 2018, allowing for the production of generic versions of the drug. Generic drugs are generally less expensive than their brand name counterparts due to increased competition among manufacturers. Optum Perks also highlights that generic drugs are often a cost-effective alternative to brand name medications. A study published in the National Center for Biotechnology Information supports this, indicating that generic drugs can provide substantial cost savings for patients. Overall, opting for Tigecycline generics can offer a more affordable option for individuals in need of this medication.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/TIGECYCLINE
[2] https://perks.optum.com/drug/tigecycline
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532699/